Why iRhythm Technologies Stock Is Crashing Today

Keith Speights, The Motley Fool
·2-min read
Why iRhythm Technologies Stock Is Crashing Today

Novitas' new Medicare reimbursement rates translate to significantly lower revenue for the cardiac care company.